Description
Medicube Zero Pore Serum 2.0 is a exfoliating face serum for special condition skin.A milky serum with a delicate texture, designed to reduce sebum production and refine the appearance of enlarged pores. Thanks to a formula enriched with extracts of Japanese camellia flowers, cinnamon bark and lemongrass, the product tones and refreshes the skin, offering an astringent and antioxidant action. The addition of silicones improves the feeling of application, while helping to retain moisture and smooth the skin surface, giving an even and silky appearance. Zero Pore Serum 2.0 is ideal for all skin types, but is particularly useful for oily and acne-prone skin, acting effectively as a daily morning and evening treatment.
More information
Ingredients: Aqua, Butylene Glycol, Dimethicone/Vinyl Dimethicone Crosspolymer, Cyclopentasiloxane, Cetyl Ethylhexanoate, Cyclohexasiloxane, Polysorbate 60, Bis-PEG-18 Methyl Ether Dimethyl Silane, Dimethicone, Phenoxyethanol, Glyceryl Stearate, PEG-100 Stearate, Chlorphenesin, Tromethamine, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Polyacrylate-13, Ethylhexylglycerin, Caprylyl Glycol, Isoceteth-10, Isoceteth-25, Parfum, Polyisobutene, Carbomer, Disodium EDTA, Mentha Rotundifolia Leaf Extract, Citrus Aurantifolia (Lime) Peel Extract, Cymbopogon Schoenanthus Extract, Polysorbate 20, Sorbitan Isostearate, Camellia Japonica Flower Extract, Fomes Officinalis (Mushroom) Extract, 1,2-Hexanediol, Cinnamomum Zeylanicum Bark Extract, Uncaria Gambir Extract, Nelumbo Nucifera Flower Extract, Pelargonium Graveolens Extract, Sanguisorba Officinalis Root Extract, BHT, Sodium Polyacrylate, Pinus Palustris Leaf Extract, Pueraria Lobata Root Extract, Ulmus Davidiana Root Extract, Oenothera Biennis (Evening Primrose) Flower Extract, Linalool, Limonene
Features
| Brand | Medicube |
|---|---|
| Skin Type | Special Conditions |
| Body Part | Face |
| Product Type | Serum |
| EAN code | 8800240569181 |
| Concern | Exfoliate |
| Capacity | 40 ml |
| SKU | MCU-B-22702 |


There are no reviews yet.